Logo image of SRI

STONERIDGE INC (SRI) Stock Fundamental Analysis

USA - NYSE:SRI - US86183P1021 - Common Stock

6.945 USD
+0.14 (+1.98%)
Last: 11/3/2025, 2:48:34 PM
Fundamental Rating

3

Overall SRI gets a fundamental rating of 3 out of 10. We evaluated SRI against 82 industry peers in the Automobile Components industry. While SRI seems to be doing ok healthwise, there are quite some concerns on its profitability. SRI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SRI has reported negative net income.
SRI had a positive operating cash flow in the past year.
SRI had negative earnings in 4 of the past 5 years.
Of the past 5 years SRI 4 years had a positive operating cash flow.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SRI has a worse Return On Assets (-4.65%) than 84.15% of its industry peers.
With a Return On Equity value of -11.42%, SRI is not doing good in the industry: 78.05% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.65%
ROE -11.42%
ROIC N/A
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

In the last couple of years the Operating Margin of SRI has declined.
SRI has a Gross Margin of 21.00%. This is in the lower half of the industry: SRI underperforms 68.29% of its industry peers.
In the last couple of years the Gross Margin of SRI has declined.
The Profit Margin and Operating Margin are not available for SRI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

SRI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SRI has more shares outstanding
Compared to 5 years ago, SRI has more shares outstanding
SRI has a worse debt/assets ratio than last year.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

SRI has an Altman-Z score of 2.40. This is not the best score and indicates that SRI is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.40, SRI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
SRI has a debt to FCF ratio of 5.33. This is a neutral value as SRI would need 5.33 years to pay back of all of its debts.
The Debt to FCF ratio of SRI (5.33) is better than 82.93% of its industry peers.
SRI has a Debt/Equity ratio of 0.63. This is a neutral value indicating SRI is somewhat dependend on debt financing.
SRI has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: SRI underperforms 74.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.33
Altman-Z 2.4
ROIC/WACCN/A
WACC9.35%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SRI has a Current Ratio of 2.14. This indicates that SRI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SRI (2.14) is better than 76.83% of its industry peers.
SRI has a Quick Ratio of 1.35. This is a normal value and indicates that SRI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.35, SRI is doing good in the industry, outperforming 78.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.35
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

SRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -764.29%.
The Revenue has decreased by -6.99% in the past year.
Measured over the past years, SRI shows a small growth in Revenue. The Revenue has been growing by 1.71% on average per year.
EPS 1Y (TTM)-764.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.06%
Revenue 1Y (TTM)-6.99%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-3.84%

3.2 Future

Based on estimates for the next years, SRI will show a very strong growth in Earnings Per Share. The EPS will grow by 59.96% on average per year.
SRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.18% yearly.
EPS Next Y9.74%
EPS Next 2Y59.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.93%
Revenue Next 2Y1.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 26.45, which means the current valuation is very expensive for SRI.
Based on the Price/Forward Earnings ratio, SRI is valued a bit more expensive than 71.95% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SRI to the average of the S&P500 Index (22.55), we can say SRI is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 26.45
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SRI is valued a bit more expensive than the industry average as 63.41% of the companies are valued more cheaply.
SRI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SRI is cheaper than 95.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.31
EV/EBITDA 10.88
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as SRI's earnings are expected to grow with 59.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.96%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STONERIDGE INC

NYSE:SRI (11/3/2025, 2:48:34 PM)

6.945

+0.14 (+1.98%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners92.61%
Inst Owner Change-2.02%
Ins Owners2.26%
Ins Owner Change4.4%
Market Cap194.53M
Revenue(TTM)877.92M
Net Income(TTM)-29739000
Analysts84
Price Target16.32 (134.99%)
Short Float %0.53%
Short Ratio0.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-111.49%
Min EPS beat(2)-175.03%
Max EPS beat(2)-47.95%
EPS beat(4)0
Avg EPS beat(4)-241.39%
Min EPS beat(4)-397.03%
Max EPS beat(4)-47.95%
EPS beat(8)3
Avg EPS beat(8)4.55%
EPS beat(12)6
Avg EPS beat(12)18.24%
EPS beat(16)8
Avg EPS beat(16)13.57%
Revenue beat(2)2
Avg Revenue beat(2)2.36%
Min Revenue beat(2)1.8%
Max Revenue beat(2)2.92%
Revenue beat(4)2
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)2.92%
Revenue beat(8)3
Avg Revenue beat(8)-1.01%
Revenue beat(12)7
Avg Revenue beat(12)1.69%
Revenue beat(16)10
Avg Revenue beat(16)3.27%
PT rev (1m)0%
PT rev (3m)14.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)-31.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.45
P/S 0.22
P/FCF 6.31
P/OCF 3.77
P/B 0.75
P/tB 1.08
EV/EBITDA 10.88
EPS(TTM)-0.93
EYN/A
EPS(NY)0.26
Fwd EY3.78%
FCF(TTM)1.1
FCFY15.85%
OCF(TTM)1.84
OCFY26.51%
SpS31.34
BVpS9.3
TBVpS6.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.65%
ROE -11.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21%
FCFM 3.51%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.54%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
F-Score4
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.33
Debt/EBITDA 5.86
Cap/Depr 63.18%
Cap/Sales 2.36%
Interest Coverage N/A
Cash Conversion 183.72%
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.35
Altman-Z 2.4
F-Score4
WACC9.35%
ROIC/WACCN/A
Cap/Depr(3y)90.27%
Cap/Depr(5y)89.37%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-764.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.06%
EPS Next Y9.74%
EPS Next 2Y59.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.99%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-3.84%
Revenue Next Year-4.93%
Revenue Next 2Y1.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124.28%
EBIT growth 3YN/A
EBIT growth 5Y-43.57%
EBIT Next Year178.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y308.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y158.7%
OCF growth 3YN/A
OCF growth 5Y14.27%

STONERIDGE INC / SRI FAQ

What is the fundamental rating for SRI stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRI.


What is the valuation status for SRI stock?

ChartMill assigns a valuation rating of 3 / 10 to STONERIDGE INC (SRI). This can be considered as Overvalued.


How profitable is STONERIDGE INC (SRI) stock?

STONERIDGE INC (SRI) has a profitability rating of 1 / 10.


How financially healthy is STONERIDGE INC?

The financial health rating of STONERIDGE INC (SRI) is 5 / 10.